List of Excipients in API silver sulfadiazine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing silver sulfadiazine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Liberty Pharmaceuticals Inc | SILVER SULFADIAZINE | silver sulfadiazine | 0440-0124 | ISOPROPYL MYRISTATE | |
| Liberty Pharmaceuticals Inc | SILVER SULFADIAZINE | silver sulfadiazine | 0440-0124 | METHYLPARABEN | |
| Liberty Pharmaceuticals Inc | SILVER SULFADIAZINE | silver sulfadiazine | 0440-0124 | PETROLATUM | |
| Liberty Pharmaceuticals Inc | SILVER SULFADIAZINE | silver sulfadiazine | 0440-0124 | POLYOXYL 40 STEARATE | |
| Liberty Pharmaceuticals Inc | SILVER SULFADIAZINE | silver sulfadiazine | 0440-0124 | PROPYLENE GLYCOL | |
| Liberty Pharmaceuticals Inc | SILVER SULFADIAZINE | silver sulfadiazine | 0440-0124 | SORBITAN MONOOLEATE | |
| Liberty Pharmaceuticals Inc | SILVER SULFADIAZINE | silver sulfadiazine | 0440-0124 | STEARYL ALCOHOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing silver sulfadiazine
Detailed excipient profiles for silver sulfadiazine
Excipient focus: CETYL ALCOHOL
silver sulfadiazine drug variants containing CETYL ALCOHOL
silver sulfadiazine drug variants not containing CETYL ALCOHOL
Excipient focus: ISOPROPYL MYRISTATE
silver sulfadiazine drug variants containing ISOPROPYL MYRISTATE
silver sulfadiazine drug variants not containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
silver sulfadiazine drug variants containing METHYLPARABEN
silver sulfadiazine drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
silver sulfadiazine drug variants containing PETROLATUM
silver sulfadiazine drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 STEARATE
silver sulfadiazine drug variants containing POLYOXYL 40 STEARATE
silver sulfadiazine drug variants not containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | silver sulfadiazine | 50090-7447 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 STEARATE TYPE I
silver sulfadiazine drug variants containing POLYOXYL 40 STEARATE TYPE I
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | silver sulfadiazine | 50090-7447 |
| >Company | >Ingredient | >NDC |
silver sulfadiazine drug variants not containing POLYOXYL 40 STEARATE TYPE I
Excipient focus: PROPYLENE GLYCOL
silver sulfadiazine drug variants containing PROPYLENE GLYCOL
silver sulfadiazine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
silver sulfadiazine drug variants containing SODIUM HYDROXIDE
silver sulfadiazine drug variants not containing SODIUM HYDROXIDE
Excipient focus: SORBITAN MONOOLEATE
silver sulfadiazine drug variants containing SORBITAN MONOOLEATE
silver sulfadiazine drug variants not containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
silver sulfadiazine drug variants containing STEARYL ALCOHOL
silver sulfadiazine drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
silver sulfadiazine drug variants containing WATER
silver sulfadiazine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
